Efficacy of Various Doses of Hydroxychloroquine in Pre-Exposure Prophylaxis for COVID 19
Status:
Recruiting
Trial end date:
2020-09-25
Target enrollment:
Participant gender:
Summary
Hydroxychloroquine has been approved by FDA as one of the treatment options for COVID
19.Healthcare personnel are amongst those at highest risk to contract the disease. Several
health authorities are now recommending the use of hydroxychloroquine as pre-exposure
prophylaxis is in health care personnel. Several studies are on going in this context.
However there is a controversy regarding the dosage regimen. This drug has a half life of
22.4 days. In this study we will be comparing three different doses of Hydroxychloroquine and
additionally have a control group in order to determine the efficacy of hydroxychloroquine as
pre- exposure prophylaxis in healthcare personnel in various doses.